<DOC>
	<DOCNO>NCT01925313</DOCNO>
	<brief_summary>Study objectives - To compare safety pharmacokinetic property CJ-30044 bepotastine besylate single oral administration healthy male volunteer . - To evaluate food-effect pharmacokinetics CJ-30044 single oral administration healthy male volunteer .</brief_summary>
	<brief_title>A Randomized , Open Label , Three-Treatment , Three-Period , Six-Sequence Crossover Study To Compare Safety Pharmacokinetic Properties CJ-30044 Bepotastine Besilate To Investigate Food-effect Pharmacokinetics CJ-30044 Healthy Adult Male Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Male volunteer age 20 45 year old BMI ( Body Mass Index ) range 18.5 25kg/m2 2 . Subject history significant chronic disease 3 . Judged good health basis vital sign , ECG , physical exam routine laboratory data trial investigator 4 . Willing adhere protocol requirement sign inform consent form 1 . History clinically significant allergy , include Bepotastine . 2 . History clinically significant hepatic , renal , neurology , psychiatric , pulmonary , endocrine , hematologic , cardiovascular disease 3 . History surgery except gastrointestinal disease might significantly change absorption medicine 4 . Subjects consider unsuitable health basis vital sign , ECG , physical exam routine laboratory data trial investigator . 5 . Clinical laboratory test value outside accept normal range AST ALT &gt; 1.25 time normal range Total bilirubin &gt; 1.5 time normal range 6 . Estimated GFR ( Glomerular Filtration Rate ) &lt; 80 mL/min/1.73m2 7 . Clinically significant vital sign SBP ( Systolic Blood Pressure ) ≤ 90 mmHg SBP ≥ 150 mmHg DBP ( Diastolic Blood Pressure ) ≤ 50 mmHg DBP ≥ 100 mmHg 8 . History drug abuse positive urine screen drug 9 . History caffeine , alcohol , smoke abuse caffeine &gt; 5 cups/day alcohol &gt; 210g/week smoking &gt; 10 cigarettes/day 10 . Special diet know interfere absorption , distribution , metabolism excretion drug ( especially , consumption grapefruit juice ) within 7 day prior drug administration 11 . Use prescription medicine oriental medicine within 14 day dose use nonprescription medicine within 7 day dose 12 . Participated previous clinical trial within 60 day prior dose 13 . Donated blood within 60 day prior dose 14 . Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>